Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8HGA

Monomer structure of transforming growth factor beta induced protein (TGFBIp) G623R fibril

Summary for 8HGA
Entry DOI10.2210/pdb8hga/pdb
DescriptorTransforming growth factor-beta-induced protein ig-h3 (1 entity in total)
Functional Keywordspathological fibrils, tgfbi related corneal dystrophy, protein fibril
Biological sourceHomo sapiens (human)
Total number of polymer chains4
Total formula weight10191.69
Authors
Low, J.Y.K.,Pervushin, K. (deposition date: 2022-11-14, release date: 2023-07-26, Last modification date: 2024-05-15)
Primary citationLow, J.Y.K.,Shi, X.,Anandalakshmi, V.,Neo, D.,Peh, G.S.L.,Koh, S.K.,Zhou, L.,Abdul Rahim, M.K.,Boo, K.,Lee, J.,Mohanram, H.,Alag, R.,Mu, Y.,Mehta, J.S.,Pervushin, K.
Release of frustration drives corneal amyloid disaggregation by brain chaperone.
Commun Biol, 6:348-348, 2023
Cited by
PubMed Abstract: TGFBI-related corneal dystrophy (CD) is characterized by the accumulation of insoluble protein deposits in the corneal tissues, eventually leading to progressive corneal opacity. Here we show that ATP-independent amyloid-β chaperone L-PGDS can effectively disaggregate corneal amyloids in surgically excised human cornea of TGFBI-CD patients and release trapped amyloid hallmark proteins. Since the mechanism of amyloid disassembly by ATP-independent chaperones is unknown, we reconstructed atomic models of the amyloids self-assembled from TGFBIp-derived peptides and their complex with L-PGDS using cryo-EM and NMR. We show that L-PGDS specifically recognizes structurally frustrated regions in the amyloids and releases those frustrations. The released free energy increases the chaperone's binding affinity to amyloids, resulting in local restructuring and breakage of amyloids to protofibrils. Our mechanistic model provides insights into the alternative source of energy utilized by ATP-independent disaggregases and highlights the possibility of using these chaperones as treatment strategies for different types of amyloid-related diseases.
PubMed: 36997596
DOI: 10.1038/s42003-023-04725-1
PDB entries with the same primary citation
Experimental method
SOLID-STATE NMR
Structure validation

227111

數據於2024-11-06公開中

PDB statisticsPDBj update infoContact PDBjnumon